Modern Diagnostic & Research Centre Limited (BOM:544673)
India · Delayed Price · Currency is INR 71.90
-1.35 (-1.84%)
At close: Oct 1, 2026
BOM:544673 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 831.11 | 779.45 | 671.31 | 562.82 | 602.07 |
Other Revenue | 8.66 | 8.18 | 15.11 | 1.21 | 0.02 |
| 839.76 | 787.64 | 686.42 | 564.03 | 602.09 | |
Revenue Growth | 6.62% | 14.75% | 21.70% | -6.32% | - |
Cost of Revenue | 216.17 | 188.15 | 176.39 | 175.24 | 212.77 |
Gross Profit | 623.6 | 599.49 | 510.02 | 388.78 | 389.32 |
Selling, General & Admin | 300.57 | 241.47 | 224.22 | 227.97 | 182.48 |
Other Operating Expenses | 188.46 | 169.28 | 159.42 | 169.48 | 146.66 |
Operating Expenses | 540.89 | 452.66 | 422.87 | 436.12 | 365.74 |
Operating Income | 82.7 | 146.83 | 87.15 | -47.34 | 23.58 |
Interest Expense | -24.4 | -18.55 | -17.86 | -13.83 | -14.26 |
Interest & Investment Income | 1.48 | 0.28 | 0.3 | 0.87 | 3.6 |
Currency Exchange Gain (Loss) | 0.01 | 0.08 | 0 | 0.5 | 0.11 |
Other Non Operating Income (Expenses) | - | 0 | -0.2 | -0.28 | -1.41 |
EBT Excluding Unusual Items | 59.8 | 128.65 | 69.4 | -60.07 | 11.62 |
Gain (Loss) on Sale of Assets | 0.12 | 0.05 | -0.75 | 0.65 | -0.24 |
Pretax Income | 59.91 | 128.7 | 68.64 | -59.42 | 11.38 |
Income Tax Expense | 7.38 | 38.62 | 10.69 | -2.1 | 25.89 |
Net Income | 52.53 | 90.08 | 57.95 | -57.32 | -14.51 |
Net Income to Common | 52.53 | 90.08 | 57.95 | -57.32 | -14.51 |
Net Income Growth | -41.68% | 55.45% | - | - | - |
Shares Outstanding (Basic) | 15 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 15 | 11 | 11 | 11 | 11 |
Shares Change | 37.27% | - | - | - | - |
EPS (Basic) | 3.48 | 8.19 | 5.27 | -5.21 | -1.32 |
EPS (Diluted) | 3.48 | 8.19 | 5.27 | -5.21 | -1.32 |
EPS Growth | -57.51% | 55.45% | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -198.73 | 5.78 | -31.04 | -34.53 | -15.92 |
Free Cash Flow Per Share | -13.16 | 0.53 | -2.82 | -3.14 | -1.45 |
Gross Margin | 74.26% | 76.11% | 74.30% | 68.93% | 64.66% |
Operating Margin | 9.85% | 18.64% | 12.70% | -8.39% | 3.92% |
Profit Margin | 6.26% | 11.44% | 8.44% | -10.16% | -2.41% |
Free Cash Flow Margin | -23.66% | 0.73% | -4.52% | -6.12% | -2.64% |
EBITDA | 134.57 | 188.73 | 124.45 | -8.74 | 60.1 |
EBITDA Margin | 16.02% | 23.96% | 18.13% | -1.55% | 9.98% |
D&A For EBITDA | 51.86 | 41.9 | 37.3 | 38.6 | 36.52 |
EBIT | 82.7 | 146.83 | 87.15 | -47.34 | 23.58 |
EBIT Margin | 9.85% | 18.64% | 12.70% | -8.39% | 3.92% |
Effective Tax Rate | 12.32% | 30.01% | 15.58% | - | 227.55% |
Revenue as Reported | 841.37 | 788.05 | 686.72 | 566.05 | 605.79 |
Advertising Expenses | 9.75 | 6.37 | 5.62 | 2.15 | 4.84 |